Dina Lynch

• Collaborated with executive team members on major decisions regarding strategic initiatives for launch of RBT-1 in CABG
• Built the Market Access infrastructure for distribution, pricing and contracting, payer strategy and reimbursement for RBT-1 launch

Led Market Access function for start up biotech company launching first oral for the treatment of early stage Alzheimers in APOE 4 patients

• Analyzed market trends to identify opportunities for growth within existing markets or new ones.
• Created the pricing and contracting platform for launch pricing
• Researched the reimbursement landscape to influence coverage for Alzheimers treatments
• Identified key distribution partners for specialty drug launch

• Promoted to VP of Sales role and oversaw 6 direct sales managers and 50 contract sales representatives.
• Quickly turned around a struggling sales organization. Under my leadership we saw an 21% increase YOY in gross sales.
• Created the Market Access and Managed Care department for commercial-stage biopharmaceutical company engaged in developing innovative antibiotic agents.
• Defined trade, pricing, contracting, payer value proposition, and reimbursement strategy.
• Served as subject matter expert on health policy, payer and reimbursement strategy, gross-to-net, and government pricing for product pipeline, and aligned internal cross-functional teams that support company objectives.
• Hired, trained, and mentored team of National Account Directors and other personnel.
• Prepared and presented information to Board of Directors and Investors, and leveraged analytics to identify opportunities.
• Built and managed sales organization for 2019 launch of novel anti-infective agent, defined sales and market strategy, and developed and implemented tactical sales and territory plans.
• Led two separate departments and was recognized for developing talent that led to increased retention and promotion. Oversaw 6 direct report and over 60 outsourced sales reps.
• Mentored and developed by Chief Executive Officer for future Chief Commercial Officer roles.
• Collaborated with senior leadership to raise private funding and co-created strategic development plan.

• Recruited to build Market Access Department for start-up biopharmaceutical company and serving as key member of Executive Team and Pricing Committee.
• Built dynamic team across multiple functional areas including Trade, Pricing and Contracting, Payer Value Proposition and Strategy, Reimbursement HUB, and Field teams.
• Hired, trained, and mentored personnel, provided strategic leadership, and collaborated with cross-functional personnel in support of organizational objectives including Medical, Legal, Finance, Regulatory, and Compliance teams.
• Played key role in the February 2016 launch of OTIPRIO, securing 'C' code for pass through payment under Outpatient Prospective Payment System (OPPS) in July 2016, and 'J' code under Healthcare Common Procedure Coding System (HCPCS) in January 2017 after initial denial by CMS.
• Developed and executed all Specialty Distribution trade strategy, increased gross-to-net (GTN) by 4%, and aligned managed care strategies to optimize market performance.

• Served as key member of Executive Team for a start-up biopharmaceutical company developing specialty drugs to treat gastrointestinal infections.
• Established vision and leadership of payer strategy and market access, managed contracting complexities, and managed vendor performance to support timely and accurate reimbursement.
• Managed a team comprised of National Account Directors, Reimbursement, and Access Trade personnel responsible for managing relationships with public and private payers, institutional accounts, group purchasing organizations, long-term care national pharmacy providers, wholesalers, and pharmaceutical benefits managers.
• Developed and executed access policy and strategy including market access, payer, managed customer, pricing and contracting, reimbursement, and trade strategy for antibacterial drug Dificid.
• Drove innovation with pricing, contracting, value-based agreements, channel strategy and process, and led the execution of marketing plans and market access strategy across the organization.
• Held senior position on Pricing Committee to develop and influence contracting strategy for current and future pipeline.

• Led contracting, access and reimbursement strategies across Southwest, managing relationships with regional commercial payers including Blue Cross Blue Shield, MercyCare, APIPA, HealthChoice, Presbyterian Health Plan, and Lovelace Healthplan.
• Cultivated relationships with key stakeholders including Pharmacy and Medical Directors to influence key decision makers and increase product utilization.
• Developed and implemented strategies to increase access and created Key Opinion Leaders to drive product utilization.
• Managed medical benefit policy for the portfolio including Medicaid programs in both Arizona and New Mexico.

• Managed team of 9 Government Payer Managers and Provider Reimbursement Managers across the Western region.
• Collaborated with cross-functional teams in support of company objectives and remediation of reimbursement issues.
• Managed departmental budgets and vendor relationships, provided support to Payer Managers and Reimbursement Managers in the development and deployment of tactical plans for Medicare contracts, and provider coverage, coding, and payment services.
• Spearheaded integration of Field Reimbursement Team and Hotline Reimbursement Services after Roche acquisition.
• Defined strategic direction and developed effective strategies to minimize reimbursement barriers and optimized access to portfolio of Roche products.

• Managed Integrated Delivery Network hospital contracts for Roche portfolio of drugs including CellCept, Tamiflu, and Mircera in Arizona, Colorado, and New Mexico.
• Responsible for pull-through strategy for National Accounts including VHA, Columbia HCA, Novation, and Premiere.
• Directly contracted portfolio of products to Banner Health, U. of AZ, U of CO, Lovelace, and Presbyterian Hospitals.